Martínez-Vega Ruth Aralí, Bolívar-Grimaldos Alix, Rincón-Orozco Bladimiro
. Universidad de Santander, Escuela de Medicina, Bucaramanga, Colombia. Email:
. Laboratorios Bolívar, Bucaramanga, Colombia. Email:
Rev Cuid. 2023 Mar 29;13(3):e2657. doi: 10.15649/cuidarte.2657. eCollection 2022 Sep-Dec.
There are few reports assessing anti-SARS-CoV-2 seroprevalence in the migrant population in the world. These studies help to understand the exposure of populations to the virus to take actions to reduce the impact of SARS-CoV-2 infection.
To determine the anti-SARS-CoV-2 seroprevalence in migrants with a vocation for permanence in Bucaramanga and to identify factors associated with previous SARS-CoV-2 infection.
Analytical cross-sectional study using consecutive sampling, which included adult migrants in Bucaramanga in February 2021. Surveys were conducted, and chemiluminescent immunoassays were performed to detect IgM and IgG antibodies to SARS-CoV-2 in serum samples. Prevalence ratios (PR) were estimated using a log-binomial regression model.
The study enrolled 462 participants. IgM seroprevalence was 11.7% (95% CI 9.1-14.9), IgG seroprevalence was 32.9% (95% CI 28.8-37.3), and IgM or IgG seroprevalence was 36.1% (95% CI 31.9-40.6). Contact with a confirmed case of COVID-19 (PR:1.54; 95% CI 1.04-2.29) or suspected case (PR:1.56; 95% CI 1.13-2.16); living with six or more people (PR: 1.52; 95% CI 1.05-2.20); stay in Colombia > 2 years (PR:1.43; 95% CI 1.11-1.92), and presence of symptoms (PR:1.62; 95%CI 1.26-2.10) were some factors associated with higher IgG seroprevalence.
In Bucaramanga, SARS-CoV-2 seroprevalence among migrants was similar to the seroprevalences of migrants in Kuwait but lower than migrants in Paris and Singapore.
The anti-SARS-CoV-2 seroprevalence among migrants with a vocation for permanence was similar to that reported among residents of Bucaramanga. Contact with suspected or confirmed COVID-19 cases and crowded conditions were some of the factors associated with seroprevalence.
世界上评估移民人群中抗SARS-CoV-2血清流行率的报告较少。这些研究有助于了解人群对该病毒的暴露情况,以便采取行动减少SARS-CoV-2感染的影响。
确定打算永久居住在布卡拉曼加的移民中抗SARS-CoV-2血清流行率,并确定与既往SARS-CoV-2感染相关的因素。
采用连续抽样的分析性横断面研究,纳入了2021年2月在布卡拉曼加的成年移民。进行了调查,并对血清样本进行化学发光免疫分析以检测抗SARS-CoV-2的IgM和IgG抗体。使用对数二项回归模型估计患病率比(PR)。
该研究纳入了462名参与者。IgM血清流行率为11.7%(95%CI 9.1-14.9),IgG血清流行率为32.9%(95%CI 28.8-37.3),IgM或IgG血清流行率为36.1%(95%CI 31.9-40.6)。与确诊的COVID-19病例(PR:1.54;95%CI 1.04-2.29)或疑似病例(PR:1.56;95%CI 1.13-2.16)接触;与六人或更多人一起生活(PR:1.52;95%CI 1.05-2.20);在哥伦比亚停留超过2年(PR:1.43;95%CI 1.11-1.92),以及出现症状(PR:1.62;95%CI 1.26-2.10)是与较高IgG血清流行率相关的一些因素。
在布卡拉曼加,移民中的SARS-CoV-2血清流行率与科威特移民的血清流行率相似,但低于巴黎和新加坡的移民。
打算永久居住的移民中抗SARS-CoV-2血清流行率与布卡拉曼加居民中报告的情况相似。与疑似或确诊的COVID-19病例接触以及拥挤的居住条件是与血清流行率相关的一些因素。